Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tvardi Therapeutics (TVRD) Accumulated Depreciation & Amortization (2016 - 2025)

Tvardi Therapeutics' Accumulated Depreciation & Amortization history spans 13 years, with the latest figure at $100000.0 for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed 0.0% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 0.0% change, with the full-year FY2025 number at $100000.0, changed 0.0% from a year prior.
  • Accumulated Depreciation & Amortization hit $100000.0 in Q4 2025 for Tvardi Therapeutics, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for TVRD hit a ceiling of $1.7 million in Q4 2023 and a floor of $100000.0 in Q4 2024.
  • Historically, Accumulated Depreciation & Amortization has averaged $887400.0 across 5 years, with a median of $1.2 million in 2021.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 21.36% in 2022 and later tumbled 94.0% in 2024.
  • Tracing TVRD's Accumulated Depreciation & Amortization over 5 years: stood at $1.2 million in 2021, then increased by 21.36% to $1.4 million in 2022, then grew by 18.31% to $1.7 million in 2023, then tumbled by 94.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for TVRD at $100000.0 in Q4 2025, $100000.0 in Q4 2024, and $1.7 million in Q4 2023.